Top News

Mabvax Finds $500K




San Diego-based Mabvax Pharmaceuticals, which is developing vaccines and human antibodies targeted at treating cancer, has gained $500,000 out of a $4M funding round, according to a regulatory filing from the firm. Mabvax had previously raised $8M in Series A funds from GBP Capital in February of 2008. No details on the new round have been released by the firm. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel